Paper Mulberry (Broussonetia papyrifera)
What Is Paper Mulberry?
Paper Mulberry is catalogued in the Materia Medica under the binomial Broussonetia papyrifera, a plant of the Moraceae family, native to East Asia. The material in circulation is bark, fruit — bark, stripped from stem or trunk. Most people search for it simply as Paper Mulberry; suppliers, pharmacopoeias and interaction databases list it as Broussonetia papyrifera, and matching the two is the first step in identifying what is actually in a product. In the hand it reads as faintly sweet, papery — a practical marker of freshness and correct identification.
The written history of Paper Mulberry begins with household and practitioner use — recipes, harvesting notes and cautions passed between regions — and only much later with laboratory description of what the bark, fruit contains. Beyond its practical use it carries cultural associations — Japanese Shinto rope material — sacred kōzo cordage.
Today most searches for Paper Mulberry come from people reading about liver support, energy and kidney support, or checking how it sits alongside a medication they already take. The use most often documented in the literature is liver-kidney yin tonic (fruit — Chu Shi Zi), followed by skin-brightening topical (aristolochic-acid-FREE tyrosinase inhibitors).
How Does Paper Mulberry Work?
Paper Mulberry is not a single active substance. Its chemistry is a mixture, and the fractions that researchers isolate most often are Flavonoids. Flavonoids is the fraction most often standardised in extracts, associated in the literature with broad-spectrum antioxidant polyphenols.
Traditional practice described Paper Mulberry in terms of taste, warmth and preparation rather than molecules — a working vocabulary that predicted which extractions were worth making long before any compound was isolated.
Published research is limited, leaning on small trials, laboratory work and animal models, and this profile cites 1 source. Reported findings centre on fruit and bark: broussonins, kazinols, prenylated flavonoids with tyrosinase inhibition. Where research exists, it examines liver-kidney yin tonic (fruit — Chu Shi Zi), skin-brightening topical (aristolochic-acid-FREE tyrosinase inhibitors) and astringent bark decoction. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
The reason Paper Mulberry is treated as its own entry rather than a substitute for a related plant is proportion: related species share several of these compound classes, but not in the same ratio or concentration.
Because these constituents are processed by the same pathways that handle many medicines, Paper Mulberry is documented as interacting with none significant. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Paper Mulberry can differ substantially; this is why reference entries specify bark, fruit and, where they exist, standardisation markers.